Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.91
  • Today's Change0.006 / 0.66%
  • Shares traded452.27k
  • 1 Year change+6.56%
  • Beta0.2830
Data delayed at least 15 minutes, as of Sep 30 2024 15:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on $1000

1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+21.99%
NAVBioPharma Credit PLC (Ordinary Share)--
Morningstar's BenchmarkNo benchmark--

Events & Activity

  • BPCR:LSE price moved over -2.41% to 0.8861
  • BPCR:LSE price falls below 200-day moving average to 0.8861 at 04:00 BST
  • BPCR:LSE price falls below 50-day moving average to 0.8861 at 04:00 BST
  • BPCR:LSE price falls below 15-day moving average to 0.8861 at 04:00 BST

Key statistics

As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.91, -3.60% below its 52-week high of 0.944, set on Jan 30, 2024.
52-week range
Today
0.81Nov 09 20230.944Jan 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.20bn
Market cap1.06bn USD
Total assets1.19bn USD
Total expense ratio1.15%
High0.91
Low0.902
Previous close0.904
Average volume564.57k
YTD Change+8.33%
Beta0.2830
Diluted NAV (est)0.9923
Diluted NAV (last pub)0.998
Premium/Discount-8.89%
Net Gearing0.00%
Annual div (ADY)0.07
USD
Annual div yield (ADY)7.74%
Div ex-dateSep 26 2024
Div pay-dateOct 29 2024
Data delayed at least 15 minutes, as of Sep 30 2024 15:19 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.